, Volume 14, Issue 5, pp 634-644

Nuclear cardiology will remain the “gatekeeper” over CT angiography

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Conclusion

Although CTA is a promising new modality, from an evidence-based point of view there is no data to support its use in a testing strategy, its accuracy is unlikely to be sufficiently similar to invasive catheterization to be considered its equivalent, and most importantly, it appears that stress perfusion data will be needed to select which patients may most benefit from revascularization and, hence, referral to the catheterization laboratory.

An erratum to this article is available at http://dx.doi.org/10.1016/j.nuclcard.2007.10.002.